News Conference News EuroPCR 2025 Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI Michael O'Riordan May 20, 2025
News Conference News AHA 2023 Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina Michael O'Riordan November 11, 2023
News Conference News ESC 2023 FIRE: Complete Revascularization Best Even for Elderly Patients With MI Michael O'Riordan August 26, 2023
News Conference News ACC 2022 No Difference in 1-Year QoL Between FFR-Guided PCI and CABG: FAME-3 Michael O'Riordan April 13, 2022
News Conference News ACC 2022 FLAVOUR: FFR as Good as IVUS for Intermediate Coronary Stenoses Michael O'Riordan April 06, 2022
News Conference News TCT 2021 FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD Michael O'Riordan November 04, 2021
News Conference News TCT 2020 Fewer Events and Symptoms With iFR-Optimized PCI, Suggests DEFINE-PCI Trial Michael O'Riordan October 17, 2020
News Conference News ACC 2019 High Rate of Residual Ischemia After PCI Despite Excellent Angiographic Outcomes: DEFINE-PCI Michael O'Riordan March 21, 2019
News Conference News ESC 2018 New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All Michael O'Riordan August 29, 2018
News Conference News EuroPCR 2018 Modest Benefit of PCI Over Medical Therapy in Patients With ‘Grey Zone’ FFR Lesions Michael O'Riordan May 23, 2018
News Conference News EuroPCR 2018 FFR-Guided PCI Reduces Risk of Death/MI Compared With Medical Therapy: Pooled Analysis Michael O'Riordan May 22, 2018
News Conference News CRT 2017 Pressure Wire Helps Identify Severe Aortic Stenosis in Paradoxical Low-Flow/Low-Gradient Cases Michael O'Riordan February 21, 2017
News Conference News AHA 2016 Shaky FUTURE? FFR Takes a Hit With Mortality Signal in French Study Michael O'Riordan November 14, 2016